NCT02872753View on ClinicalTrials.gov

Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

August 11, 2017

Study Completion Date

January 31, 2023

Conditions
Meniscectomy
Interventions
BIOLOGICAL

ACP

Autologous Conditioned Plasma will be obtained directly in the operatory room from the peripheral venous blood of the patient, and injected intra-articularly at the end of arthroscopic meniscectomy

OTHER

Standard Meniscectomy

Patients will receive standard arthroscopic meniscectomy

Trial Locations (1)

40136

Rizzoli Orthopaedic Institute, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER

NCT02872753 - Intra-operative Injection of Autologous Conditioned Plasma (ACP) Following Partial Meniscectomy | Biotech Hunter | Biotech Hunter